MRI characterization of paranodal junction failure and related spinal cord changes in mice

PLoS One. 2012;7(12):e52904. doi: 10.1371/journal.pone.0052904. Epub 2012 Dec 27.

Abstract

The paranodal junction is a specialized axon-glia contact zone that is important for normal neuronal activity and behavioral locomotor function in the central nervous system (CNS). Histological examination has been the only method for detecting pathological paranodal junction conditions. Recently, diffusion tensor MRI (DTI) has been used to detect microstructural changes in various CNS diseases. This study was conducted to determine whether MRI and DTI could detect structural changes in the paranodal junctions of the spinal cord in cerebroside sulfotransferase knock-out (CST-KO) mice. Here, we showed that high-resolution MRI and DTI characteristics can reflect paranodal junction failure in CST-KO mice. We found significantly lower T1 times and significantly higher T2 times in the spinal cord MRIs of CST-KO mice as compared to wild-type (WT) mice. Spinal cord DTI showed significantly lower axial diffusivity and significantly higher radial diffusivity in CST-KO mice as compared to WT mice. In contrast, the histological differences in the paranodal junctions of WT and CST-KO mice were so subtle that electron microscopy or immunohistological analyses were necessary to detect them. We also measured gait disturbance in the CST-KO mice, and determined the conduction latency by electrophysiology. These findings demonstrate the potential of using MRI and DTI to evaluate white matter disorders that involve paranodal junction failure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Axons / pathology*
  • Diffusion Tensor Imaging
  • Mice
  • Mice, Knockout
  • Nerve Fibers, Myelinated / pathology
  • Neuroglia / pathology*
  • Neurons / pathology*
  • Spinal Cord / pathology*
  • Spinal Cord / physiopathology
  • Sulfotransferases / genetics

Substances

  • Sulfotransferases
  • galactosylceramide sulfotransferase

Grants and funding

This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); by a grant from the General Insurance Association of Japan, by the JST-CIRM Collaborative Research Program, to YO and MN; by a grant from the Strategic Research Program for Brain Sciences and the Leading Project for Realization of Regenerative Medicine, support for the Core Institutes for iPS cell research from MEXT and the Funding Program for World-leading Innovative R&D on Science and Technology to HO, and by a Grant-in-aid for the Global COE program from MEXT to the Keio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.